New medication also reduces by 40 percent the number of pulmonary exacerbations, the leading cause of death in cystic fibrosis patients
Results from two phase 3 clinical trials published today in the New England Journal of Medicine show that a new combination of medications can successfully treat the underlying cause of cystic fibrosis for patients age 12 and older with two copies of the F508del gene mutation – the most common form of the life-threatening, genetic disease found in over half of the cystic fibrosis (CF) population. Approximately 8,500 people in the U.S., and 22,000 people in North America, Europe and Australia, age 12 and older with cystic fibrosis carry this gene mutation.
The international trial, which studied more than 1,000 cystic fibrosis patients age 12 and older, revealed that a combination of the drugs Kalydeco (ivacaftor) and lumacaftor, an experimental drug that has not yet been approved by the Food and Drug Administration (FDA), successfully treated the defective CF protein and improved lung function. The drugs also helped patients achieve a 40 percent reduction in pulmonary exacerbations, the leading cause of death in cystic fibrosis patients.
“Being able to treat not just the symptoms, but the underlying cause of cystic fibrosis by targeting this specific gene mutation, is a major game changer because it is by far the most common in patients with this disease,” said Dr. Bonnie Ramsey, director of the Center for Clinical and Translational Research at Seattle Children’s Research Institute and professor of Pediatrics at the University of Washington, who presented the study’s findings at the Center for Drug Evaluation and Research advisory committee meeting on May 12. “Previously, we found that Kalydeco treated just four percent of cystic fibrosis patients, but this new combination treats the defective CF protein for a much greater number of patients.”
The drugs, which work together to address the defective gene mutation by allowing the proteins within the cell to fold properly, reach the cell surface and then work as a salt channel, were given to patients over the course of 24 weeks in an effort to gain insight on how they may improve lung function and quality of life for people living with cystic fibrosis.
The trial included cystic fibrosis patients from Seattle Children’s and the University of Washington Medical Center. Today, the median predicted age of death for a person with the disease is in the mid-20s.
“What gives me tremendous confidence and excites me the most are the comprehensive health improvements seen in patients across all age groups, in all geographies and with all levels of disease severity,” said Ramsey, who was one of four lead authors on the trial and is a pioneer in cystic fibrosis treatment. “Patients can now have longer periods of good health, greatly improving their quality of life.”
The Latest on: Cystic Fibrosis
[google_news title=”” keyword=”Cystic Fibrosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cystic Fibrosis
- COMMUNITY GEMS: Kettering man, at age 70, gives hope to others with cystic fibrosison May 2, 2024 at 10:45 am
When John O’Neill was born with cystic fibrosis in 1954, his parents were told his life expectancy was about five years. But the Kettering man celebrated his 70th birthday in March and continues to ...
- Houston Happens – Mother’s Day tech, cystic fibrosis, Yellowstone documentary and moreon May 2, 2024 at 9:41 am
Houston Happens host Maggie Flecknoe has all the latest tech gifts and finds, plus annual spring events just in time for Mother’s Day. She also speaks with the board ...
- Texas Water Utilities grants 10-year-old's Disney wishon May 2, 2024 at 8:54 am
Texas Water Utilities and Make-A-Wish Central & South Texas granted the wish of a 10-year-old boy with cystic fibrosis by hosting a Disney-themed welcome back p ...
- Good Day Northern Michigan, Thursday, May 2on May 2, 2024 at 8:09 am
Talking Mother’s Day scams with Katie Grevious of the BBB Today we’re talking Mother’s Day scams with Katie Grevious of the BBB, as well as chatting with First President KC White about Cystic Fibrosis ...
- Volunteer at Great Strides Walk for Cystic Fibrosis Foundation in Santa Claritaon May 2, 2024 at 1:04 am
Come volunteer for a good cause while enjoying scenic nature in the process! The Cystic Fibrosis Foundation is holding its annual Great Strides walk in Santa Clarita on Saturday, May 4, 2024 ...
- Blake Pavey On Hard Launches, Cystic Fibrosis & Why You Shouldn't Date Comedianson May 1, 2024 at 10:30 pm
We catch up with comedian Blake Pavey to chat about how his girlfriend soft launched him, the awkward experience of getting his sperm checked and his advice to anyone thinking of dating a comedian ...
- Chapel Hill drugmaker sees positive results for lung disease treatmenton May 1, 2024 at 12:16 pm
"These results show that Arina-1 can have a profound benefit for patients," CEO Dan Copeland said in a statement. "There are currently no approved therapies for bronchiectasis, and to see such a clear ...
- A New Delivery System Offers Hope for Cystic Fibrosison May 1, 2024 at 7:52 am
CRISPR-carrying lipid nanoparticles enabled researchers to correct a rare nonsense mutation in the lungs of a cystic fibrosis mouse model.
- Man to cycle 530 kilometres to save next generation of cystic fibrosis suffererson April 30, 2024 at 7:52 am
Devoted dad Bob Clarke is cycling 530 kilometres from Vietnam’s Ho Chi Minh To Angkor Wat in Cambodia … to save cystic fibrosis patients like his treasured daughter. And CF-sufferer Sophie Clarke, 29, ...
- Organization Tips for Parents of Children With CFon April 30, 2024 at 2:00 am
Caring for a child with CF can be a lot to juggle — from the many medications and daily treatments to the endless doctor's appointments. But I’ve found a system that helps me stay organized and stress ...
via Bing News